Janus Henderson Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Janus Henderson Group’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-429,026	Closed	-$10.3M	–	2748
2023 Q1	$10.3M	Buy	+429,026	New	+$5.38M	0.01%	703

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group's PRVB Position: Q2 2023 in Review

Janus Henderson Group sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 429,026 shares — an estimated $10.3M sold.

Janus Henderson Group first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $10.3M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Janus Henderson Group reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Janus Henderson Group sold 429,026 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $10.3M.
Janus Henderson Group first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Janus Henderson Group's Provention Bio, Inc. Common Stock position peaked at $10.3M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.